Insider filing · AGIO
Brian Goff
Chief Executive Officer
profile →
Agios Pharmaceuticals, Inc.
AGIO · Healthcare · 29 filings in 24 months
ticker →
Brian Goff sold $507K of Agios Pharmaceuticals (AGIO)
Executed Dec 30 2025, disclosed Jan 2, 3 days later.
Value, as filed
$507K
18,703 sh across 2 lots
Executed
Dec 30 2025
the trade date, as filed
Disclosed
Jan 2
3 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
BGBrian Goff (Chief Executive Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Agios Pharmaceuticals, Inc. (AGIO). The largest single filing was $662K of AGIO (19,068 sh across 2 lots, as filed), executed Apr 2.
The name
AGIOHealthcare · Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the Unite…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Brian Goff in AGIO
AGIOSALE
Agios Pharmaceuticals, Inc.
$662K19,068 sh across 2 lots
Exec Apr 2
Filed Apr 6 · 5:30 PM ET AGIOSALE Agios Pharmaceuticals, Inc. $523K
18,055 sh across 3 lots
Exec Mar 2
Filed Mar 3 · 5:30 PM ET AGIOSALE Agios Pharmaceuticals, Inc. $406K
11,085 sh × $36.67
Exec Aug 8 2025
Filed Aug 12 2025 · 5:30 PM ET AGIOSALE Agios Pharmaceuticals, Inc. $627K
18,700 sh across 2 lots
Exec Jun 24 2025
Filed Jun 26 2025 · 5:30 PM ET AGIOSALE Agios Pharmaceuticals, Inc. $460K
12,947 sh across 2 lots
Exec Mar 3 2025
Filed Mar 4 2025 · 5:30 PM ET